首页> 外文会议>IEEE Signal Processing in Medicine and Biology Symposium >Decision quality support in diagnostic breast ultrasound through artificial Intelligence
【24h】

Decision quality support in diagnostic breast ultrasound through artificial Intelligence

机译:通过人工智能诊断乳房超声的决策质量支持

获取原文

摘要

Medical Ultrasonography is a valuable imaging technology for medical diagnostics and, more recently, as a screening alternative to mammography for women with dense breasts. However, ultrasound imaging within the contexts of both diagnostic and screening mammography suffers from inter-operator and intra-operator variability. Consequently, there is a broad distribution of performance profiles, even for radiologists of similar training. Typically, these profiles tend to err on the side of caution, preferring false positive errors to false negative errors. While this approach may lead to a higher Cancer Detection Rate (CDR), it also lowers the Positive Predictive Value (PPV3) of performed biopsies. A lower PPV3 translates to an increase in benign biopsies, the annual cost of which are estimated to be on the order of 1−3 billion USD (not including pathological workups). And, of course, there is the immeasurable cost of pain, worry, and suffering borne by women undergoing these potentially unnecessary procedures. In this paper, we evaluate the ability of the ClearView cCAD algorithms to increase overall performance and reduce the inter-operator variance on a set of imaged lesions. The cCAD system provides an automated assessment of some ACR BI-RADs criteria and calculates a preliminary BI-RADs assessment, given as BI-RADS categorical bucket (1-3) or (4-5). Through the evaluation of 1300 breast lesion images, 3 MQSA certified radiologists were asked to determine both a Likelihood of Malignancy (LoM) and a BI-RADs assessment, from which their ROC curve AUC as well as PPV3 could be calculated. The cCAD system was also evaluated, on the same set of lesions, by a similar set of metrics. From this analysis we have been able to show that the cCAD system outperforms radiologists at all operating points within the scope of this study design. Furthermore, we've shown that through simple fusion schemes we are able to increase performance beyond that of either the cCAD system or the radiologist alone by all typically tracked quality metrics, and significantly reduce inter-operator variance.
机译:医学超声检查是一种用于医学诊断的有价值的成像技术,最近,它作为乳房密度较高的女性的乳房X线检查的筛查替代方法。然而,在诊断和筛查乳房X线照相术的背景下的超声成像遭受操作者之间和操作者内部的可变性的困扰。因此,即使对于接受过类似培训的放射科医生来说,性能分布图的分布也很广泛。通常,这些配置文件倾向于在警告方面出错,宁愿错误肯定错误而不是错误否定错误。尽管这种方法可能会导致较高的癌症检出率(CDR),但也会降低所进行活检的阳性预测值(PPV3)。 PPV3降低意味着良性活检增加,估计其每年的费用约为1-3亿美元(不包括病理检查)。当然,接受这些可能不必要的手术的妇女所承受的痛苦,忧虑和苦难的代价是不可估量的。在本文中,我们评估了ClearView cCAD算法在一组成像病变上提高整体性能并减少操作者间差异的能力。 cCAD系统提供了一些ACR BI-RADs标准的自动评估,并计算了初步的BI-RADs评估,以BI-RADS类别(1-3)或(4-5)给出。通过评估1300个乳腺病变图像,要求3名获得MQSA认证的放射科医生确定恶性可能性(LoM)和BI-RADs评估,从而可以计算出它们的ROC曲线AUC和PPV3。还通过一组相似的指标对同一组病变上的cCAD系统进行了评估。通过此分析,我们已经能够证明,在本研究设计范围内的所有工作点上,cCAD系统的性能均优于放射科医生。此外,我们已经证明,通过所有常规跟踪的质量指标,通过简单的融合方案,我们可以将性能提高到cCAD系统或放射线医师以外的水平,并显着降低操作员之间的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号